InspireMD (NYSE:NSPR) Earns Sell Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of InspireMD (NYSE:NSPR – Free Report) in a report released on Monday. The brokerage issued a sell rating on the stock. Separately, Piper Sandler restated an “overweight” rating and issued a $4.50 price objective on shares of InspireMD in a research note on Tuesday, September 17th. Check Out Our Latest […]
22 Nov 06:08 · The Markets Daily